Dr. Navpreet Kaur, MD

Dr. Kaur practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Kaur's NPI, 1083935332, was assigned on June 21, 2010. Dr. Kaur graduated from Royal College of Surgeons Ireland in 2010. Dr. Kaur holds California license A135921.

Dr. Kaur's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Kaur's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Kaur to 2 more group practices and clinics, 1 urgent care center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 4 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Kaur is board certified in surgery by the American Board of Surgery. Dr. Kaur is licensed in California.

Dmand AI lists gallbladder removal and kidney transplant among the conditions Dr. Kaur treats.

CMS data shows 156 Medicare services from Dr. Kaur across 1 procedure code in 2024, for 37 Medicare patients. Medicare paid $10,189 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Kaur in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 59% are also on Medicaid. Their average risk score is 3.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 60, with 50% women.

In 2024, Dr. Kaur wrote 119 Medicare Part D claims for 18 patients. 86% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $394 in total drug cost. In 2023, CMS named 61 claims across 5 drugs.

Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Kaur in 2025. Dr. Kaur's most frequent co-authors are Yong Kyong Kwon, MD and Narinder Singh.

CMS Open Payments shows 47 general payments to Dr. Kaur from 12 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 53% of the total. Ethicon Inc. paid the most, $10,107.

Dr. Kaur graduated from Royal College of Surgeons Ireland in 2010.

Dr. Kaur is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.